Sign in

You're signed outSign in or to get full access.

John Xu

John Xu

Chief Executive Officer at Maison Solutions
CEO
Executive
Board

About John Xu

John Xu, 48, is President, Chief Executive Officer, and Chairman of Maison Solutions Inc. (MSS) and has served as Director, President and CEO since 2019; the company identifies him as founder/CEO with extensive operations and investment experience via J&C International Group LLC and Ideal City Realty, LLC . Under Xu’s leadership, Q3 FY2025 net revenues rose 151.1% year over year to $34.1M and EBITDA improved to $1.5M (vs. $(0.2)M prior-year), with FY2025 guidance for $120–$125M revenue and positive net income . Xu controls approximately 90.34% of MSS’s total voting power through Class A and all Class B shares, making MSS a Nasdaq “Controlled Company” that relies on governance exemptions .

Past Roles

OrganizationRoleYearsStrategic Impact
Maison Solutions Inc.President, CEO, Chairman, Director2019–presentFounding leader; oversees strategy, M&A and operations; combined CEO/Chair roles with Lead Independent Director structure .
J&C International Group LLCDirector & President2013–presentCross-border investment experience leveraged for growth initiatives .
Ideal City Realty, LLCDirector & President2009–2020Real estate investment and operational management background .

External Roles

OrganizationRoleYearsNotes
J&C International Group LLCDirector & President2013–presentCross-border investment firm .
Ideal City Realty, LLCDirector & President2009–2020Real estate investment firm .

Board Governance and Roles

  • Structure and independence: MSS is a Nasdaq “Controlled Company” because Xu holds >50% voting power; Board relies on exemptions from majority independence and from CEO pay being set solely by independent directors . Independent directors (Wang, Willis, Zhang) form all committees; Lead Independent Director is Mark Willis .
  • Committees and chairs: Audit (Chair: Bin Wang; Audit Committee Financial Expert), Compensation (Chair: Mark Willis), Nominating & Governance (Chair: Bin Wang) .
  • Board process: FY2024 Board held 3 meetings and 7 written consents; each director attended ≥75% of Board/committee meetings . Compensation Committee held no meetings and acted once by unanimous written consent in FY2024 .

Fixed Compensation

MetricFY2023FY2024FY2025 (change)
Base Salary (CEO, John Xu)$71,000 $143,000 (raised Mar 17, 2023) Increased to $180,000 effective Jan 25, 2025 (via amendment dated Aug 28, 2025)
Cash Bonus (Actual)— (no disclosure)
Other Cash/Perqs— (no disclosure)

Notes: Proxy does not disclose a target bonus % for the CEO and shows no non-equity incentive payouts for FY2023–2024 .

Performance Compensation

Incentive TypeMetric DesignWeightingTargetActual/PayoutVesting
Annual cash incentiveNot disclosed; no bonus paid FY2023–2024
Equity (RSUs/PSUs/Options)“None of our named executive officers have ever held options or other awards with values based on our interests”; no grants under 2023 plan as of 4/30/24

Clawback: MSS adopted an SEC/Nasdaq-compliant clawback policy (effective Oct 2, 2023); applies to incentive-based pay upon restatement .

Equity Ownership & Alignment

HolderClass A Shares% Class AClass B Shares% Class BVoting Power %
John Xu (incl. Stratton Arms Holding LLC and Golden Tree USA, Inc.)13,600,00077.93%2,240,000100%90.34%
Date/SourceAs of Mar 28, 2025
  • Control and alignment: Dual-class structure (10 votes/share Class B) concentrates control with Xu; risk factors highlight ability to control elections, M&A and major transactions .
  • Pledging/hedging: Insider Trading Policy mandates trading windows and pre-clearance; no explicit pledging disclosure located in provided filings .
  • Ownership guidelines: No executive ownership guideline disclosures found in proxy/10-K sections reviewed .

Employment Terms

TermDetail
Agreement start/termCEO employment agreement dated Oct 1, 2021; initial 3-year term; auto-renews for successive 3-year periods; at-will employment .
Base salary$143,000 per year per agreement; amended to $180,000 effective Jan 25, 2025 .
Non-compete/non-solicitCovenants included in agreement .
Termination/severanceIf Xu violates the agreement, Company may terminate without notice and pay one-month salary as compensation (exclusive remedy) .
Change-in-controlNo CIC severance or acceleration terms disclosed in proxy .
ClawbackCompany clawback policy applies as per SEC/Nasdaq rules .

Related Party Transactions (Governance Red Flags)

  • Payables: As of Jan 31, 2025, payables included $222,049 to John Xu; $250,000 to New Victory Foods (100% owned by Xu) for Lee Lee escrow; $440,166 to Hong Kong Supermarket of Monterey Park, Ltd. (controlled by Xu) .
  • Intercompany trade: Sales/purchases with entities controlled by Xu or spouse, including HKGF Alhambra (90% owned by spouse; MSS owns 10%), HKGF Arcadia (MSS 49%), United Food (Xu aggregate 37.5% interest), Dai Cheong Trading Co Inc. (Xu controls 90% through DC Holding; MSS owns 10%) with disclosed volumes and receivables .
  • Acquisition from spouse: 100% of GF Supermarket of MP, Inc. acquired from entities including Xu’s spouse; price amended to $2.5M (paid Oct 2023) .

Director Compensation (for governance context)

Director (Non-Employee)Cash RetainerTotal
Mark Willis$50,000$50,000
Bin Wang$50,000$50,000
Dr. Xiaoxia Zhang$50,000$50,000
NotesStandard director agreements; equity plan not yet established for directors .

Performance & Track Record

MetricQ3 FY2024Q3 FY20259M FY20249M FY2025
Net Revenues ($M)13.634.1 (+151.1% YoY) 41.194.8 (+130.6% YoY)
EBITDA ($M)(0.21)1.52 0.323.97
Net Income ($M)(0.55)~1.00 (0.56)~1.50
FY2025 GuidanceRevenues $120–$125M; net income positive

Execution updates cited expansion via consultancy agreement ($1.3M annual compensation) and integration of Lee Lee International Supermarket assets .

Risk Indicators & Red Flags

  • Financial restatement: Audit Committee determined prior FY2024 and FY2025 interim financials should not be relied upon; restatement increased cash by $2.074M related to Lee Lee acquisition; company states no impact to operating results or non-GAAP metrics and no fraud indicated .
  • Nasdaq deficiency: Received notice for bid price below $1; 180-day compliance window to Jan 6, 2026; potential reverse split considered if needed .
  • Controlled company/dual-class: Concentrated control with Xu; governance exemptions may reduce minority protections .
  • Committee activity: Compensation Committee held no meetings in FY2024, relying on unanimous written consent once .

Say-on-Pay, Peer Group, and Shareholder Engagement

  • Emerging Growth Company: MSS is an EGC and discloses reduced executive compensation detail; EGCs are exempt from nonbinding say-on-pay and golden parachute votes, per company risk factor disclosure .
  • Compensation peer group/targets: No compensation peer group, target percentile, or incentive metric disclosures identified in the latest proxy .

Equity Incentive Overhang/Dilution Context

  • Equity plan usage: As of 4/30/24, no shares issued under 2023 Stock Incentive Plan .
  • Financing instruments: 2025 SPA for convertible notes and incremental warrant includes conversion features and an Exchange Cap unless shareholders approve; potential issuance up to 62.7M shares at the floor price scenario (subject to adjustments), highlighting dilution risk (board sought approval at 2025 AGM) .
  • Authorized share increase: Proposal to raise Class A authorized shares to 150M; rationale includes equity plan flexibility and financing .

Employment Terms (Detailed Table)

ProvisionSummary
Agreement DateOct 1, 2021; initial 3-year term; auto-renew 3-year cycles; at-will .
Base Pay Updates$143,000 per agreement; amended to $180,000 effective Jan 25, 2025 .
Termination for ViolationCompany may terminate without notice; one-month salary as exclusive compensation .
Non-Compete/Non-SolicitIncluded .
CIC / Severance MultiplesNot disclosed .
ClawbackAdopted; applies on restatement .

Investment Implications

  • Alignment and retention: Xu’s cash-heavy pay with no disclosed variable incentive or equity grants suggests limited formal pay-for-performance linkage; however, extremely high personal ownership (90.34% voting power) aligns long-term control but raises minority protection concerns and reduces board leverage on compensation outcomes .
  • Selling pressure/vesting: No option/RSU overhang for Xu and no disclosed vesting schedules, implying minimal mechanical sell pressure from vesting; insider trading policy imposes trading windows and pre-clearance for insiders .
  • Governance risk: Controlled company status, combined CEO/Chair role (mitigated by Lead Independent Director), minimal Compensation Committee meeting cadence, and extensive related-party transactions heighten governance and conflict risks that could affect valuation multiples and capital access .
  • Execution momentum vs. accounting and listing risks: Financial results show strong growth post-Lee Lee integration with improved EBITDA and positive net income trajectory, albeit alongside a restatement and Nasdaq bid price deficiency that could increase volatility and financing costs until resolved .

If you’d like, I can add a Form 4 insider trading analysis for Xu to quantify any recent sales/buys and post-transaction ownership to refine views on near-term selling pressure (not included in the above filings).